JP2017105743A - Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum - Google Patents

Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum Download PDF

Info

Publication number
JP2017105743A
JP2017105743A JP2015257829A JP2015257829A JP2017105743A JP 2017105743 A JP2017105743 A JP 2017105743A JP 2015257829 A JP2015257829 A JP 2015257829A JP 2015257829 A JP2015257829 A JP 2015257829A JP 2017105743 A JP2017105743 A JP 2017105743A
Authority
JP
Japan
Prior art keywords
cells
rehmannia glutinosa
cancer
patient
polygonatum falcatum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015257829A
Other languages
Japanese (ja)
Inventor
組夫 上石
Kumio Kamiishi
組夫 上石
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2015257829A priority Critical patent/JP2017105743A/en
Publication of JP2017105743A publication Critical patent/JP2017105743A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide prophylactic and therapeutic methods of lifestyle diseases including cancer.SOLUTION: Rehmannia glutinosa and Polygonatum falcatum which are Chinese medicinal herbs are taken simultaneously. A method comprises taking every day as a medicinal liquor obtained by immersing into Sorghum bicolor liquor or ethanol with an alcoholicity of 55 degrees for about two months, or as a juice by dissolving with other solvent, or as powders by dehydration and drying, or as a tablet. The proportion of Rehmannia glutinosa and Polygonatum falcatum may be half-and-half, and daily dose is not particularly restricted. In the latest cancer immunotherapy, therapy is carried out by culturing and growing patient's dendritic cells and immune cells such as T-cells in vitro and then returning them to the patient, and the same effect without side effects as cancer immunotherapy can be obtained because immuno cells are activated naturally in a patient's body by taking Rehmannia glutinosa and Polygonatum falcatum simultaneously. In order to further promote the immune effect, improvement of the in vivo environment by osteopathic theory modern version is necessary.SELECTED DRAWING: Figure 4

Description

漢方薬草の薬理作用の現代研究で以下の効能が確認されたA modern study of the pharmacological effects of herbal medicines confirmed the following effects:

地黄：有機リンパ芽球細胞の成長促進 Ｔリンパ細胞ＮＫ細胞の増殖促進 単球細胞から発生するマクロファージの呑噬機能の促進等々免疫機能の回復Ground yellow: Growth promotion of organic lymphoblasts Promotion of proliferation of T lymphocytes NK cells Recovery of immune functions such as promotion of sputum function of macrophages generated from monocytes

黄精：ＤＮＡ／ＲＮＡ等タンパク質の合成促進 リンパ細胞の増殖促進 血液内脂肪の抑制 血糖値の抑制作用 白血球減少抑制Yellow spirit: Promote synthesis of proteins such as DNA / RNA Promote proliferation of lymphocytes Suppress blood fat Suppress blood glucose level Suppress white blood cell decrease

黄精により、核酸の生成が促進され細胞分裂時のＤＮＡ／ＲＮＡ転写ミスが減少し癌細胞発生が抑制される
また、地黄によりＴリンパ細胞、ＮＫ細胞の増殖力が強化され、発生してしまった癌細胞を攻撃し消滅させてしまう
黄精により強化された白血球の免疫機能のうち、単球からのマクロファージによる呑噬機能が癌細胞を取り込んで消滅させるThe yellow spirit promotes the generation of nucleic acids, reduces DNA / RNA transcription mistakes during cell division, and suppresses the generation of cancer cells. Also, the proliferation of T lymphocytes and NK cells has been strengthened by the ground yellow, which has occurred. Among the immune functions of leukocytes enhanced by the yellow spirit that attack and kill cancer cells, the acupuncture function by macrophages from monocytes takes in cancer cells and disappears

地黄はＴリンパ球細胞を活性化することで免疫障害を起こす攻撃抑制抗体を取り除く
地黄と黄精の共同薬事効果を最大化するための体質改善策を現代版整体理論に基づき行う事で副作用の心配もなく、マクロファージ、樹状細胞、ＮＫ細胞、Ｔ型細胞が活性化し、薬物免疫治療と同等の癌治療、予防効果を発揮するGround yellow activates T lymphocyte cells to remove immune-damaging anti-antibody antibodies. Concerns of side effects can be realized by taking a constitutional improvement plan based on modern manipulative theory to maximize the joint pharmacological effect of ground yellow and yellow spirit. In addition, macrophages, dendritic cells, NK cells, and T-type cells are activated and exert cancer treatment and prevention effects equivalent to drug immunotherapy

九州大学先端医療イノベーションセンターKyushu University Advanced Medical Innovation Center

現代版整体理論Modern manipulative theory

樹状細胞の抗体認識機能を強化しＴリンパ細胞ＮＫ細胞のがん細胞攻撃能力を蘇生させる免疫抗ガン治療法
樹状細胞の培養方法特願２０１４−０１７５６６ Immune anti-cancer therapy that enhances the antibody recognition function of dendritic cells and revives the ability of T lymphocyte NK cells to attack cancer cells
Dendritic cell culture method Japanese Patent Application No. 2014-017566

ステロイド、インスリン、シスプラチン等の抗生物質を使うことのない自然薬草である地黄、黄精の効能を使って、副作用のないガンをはじめとする糖尿病や高脂質といった生活習慣病やアトピー、花粉症等の免疫予防、治療が可能となるかを研究したUsing natural yolks and yellow spirits, which are natural herbs that do not use antibiotics such as steroids, insulin, cisplatin, etc. Researched whether immune prevention and treatment would be possible

地黄と黄精の効能成分分析を現代医学の手法で実施 遺伝子医学によるガン免疫療法での治療法をこの二種類の漢方薬草で同じ効果が確認出来るかを検証したAnalyzes of the active ingredients of ground yellow and yellow spirit using modern medical techniques We examined whether the same effect can be confirmed with these two kinds of herbal medicines in cancer immunotherapy by gene medicine

現代版整体理論 服用してきた薬の種類のみでなく食生活、ライフスタイルの違い等により、各人の体質は異なっている 西洋の薬の長期服用による活性酸素や冷え性等の問題があれば、漢方薬の効き目も変わってくる 通常の漢方薬や食事改善により薬の効く体質にまず戻すことが必要である 癌細胞撲滅のための機能分担 試作品 Modern version of manipulative theory The constitution of each person is different due to differences in diet and lifestyle as well as the types of medicines that have been taken.If there are problems such as active oxygen or coldness due to long-term use of Western medicine, Chinese medicine It is necessary to first return to a medicinal structure by improving traditional Chinese medicine and diet Functional sharing for cancer cell eradication Prototype

アルコール度５５度の高粱酒やエタノールに二か月ほど漬けて薬酒として服用する ほかの溶剤で溶かしてジュースとしても服用可Soaked in high-alcohol liquor with an alcohol content of 55 degrees or ethanol for about 2 months and taken as a medicinal liquor Can be taken as a juice by dissolving in other solvents

脱水乾燥させたものを粉状にしたものや錠剤化したものを毎日服用するTake dehydrated and dried powdered or tableted daily

地黄と黄精の比率は半々程度でよい また毎日の服用量も特に制限はないThe ratio of ground yellow to yellow spirit may be about half and the daily dose is not particularly limited

癌患者は、西洋医学の免疫細胞療法の様な樹状細胞を体外に抽出して培養するといった手間もなく自宅に居ながら地黄と黄精から成る免疫治療薬を服用するだけで癌治療等生活習慣病の治療と予防がなされるCancer patients are living in the disease such as cancer treatment just by taking immunotherapy drugs consisting of yellow and yellow while staying at home without the need to extract and culture dendritic cells outside the body like immunocytotherapy in Western medicine Treatment and prevention

Claims (1)

漢方薬草 地黄と黄精を使ったがん免疫細胞活性化によるがん治療と予防法Chinese herbal medicine Herbal cancer treatment and prevention by cancer immune cell activation using yellow and yellow spirits
JP2015257829A 2015-12-10 2015-12-10 Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum Pending JP2017105743A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015257829A JP2017105743A (en) 2015-12-10 2015-12-10 Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015257829A JP2017105743A (en) 2015-12-10 2015-12-10 Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum

Publications (1)

Publication Number Publication Date
JP2017105743A true JP2017105743A (en) 2017-06-15

Family

ID=59058989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015257829A Pending JP2017105743A (en) 2015-12-10 2015-12-10 Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum

Country Status (1)

Country Link
JP (1) JP2017105743A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112017003685T5 (en) 2016-07-22 2019-05-02 Denso Corporation Vehicle air conditioning unit

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128571A (en) * 2001-10-22 2003-05-08 Matsuura Yakugyo Kk Diabetic medicine and health food
CN101366914A (en) * 2008-09-23 2009-02-18 毕占信 Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method
CN104106763A (en) * 2014-06-19 2014-10-22 无限极（中国）有限公司 Application of polygonatum polysaccharide in preparation of drugs for assisting inhibition of colon cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128571A (en) * 2001-10-22 2003-05-08 Matsuura Yakugyo Kk Diabetic medicine and health food
CN101366914A (en) * 2008-09-23 2009-02-18 毕占信 Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method
CN104106763A (en) * 2014-06-19 2014-10-22 无限极（中国）有限公司 Application of polygonatum polysaccharide in preparation of drugs for assisting inhibition of colon cancer

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BIOTHERAPY, vol. 5, no. 12, JPN6018023211, 1991, pages 1840 - 1849 *
CARBOHYDRATE POLYMERS, vol. 96, no. 2, JPN6018023214, 2013, pages 516 - 521 *
CHINESE JOURNAL OF PHARMACOLOGY AND TOXICOLOGY, vol. 7(2), JPN6018023216, 1993, pages 153 - 156 *
GENES ENVIRONMENT, vol. 36, no. 2, JPN6018023227, 2014, pages 33 - 38 *
J,AGRIC.FOOD CHEM., vol. 59, no. 8, JPN6018023231, 2011, pages 3747 - 3753 *
中国中薬雑誌, vol. 24, no. 11, JPN6018023218, 1999, pages 663 - 666 *
中国老年学雑誌, vol. 33(15), JPN6018023220, 2013, pages 3659 - 3662 *
中国食品添加剤, vol. No.4, JPN6018023223, 2008, pages 52 - 55 *
中草薬, vol. 37, no. 8, JPN6018023225, 2006, pages 1132 - 1134 *
南京中医薬大学学報, vol. 26, no. 6, JPN6018023221, 2010, pages 479 - 480 *
肝臓, vol. Vol.53,No.Supplement, JPN6018023229, 2012, pages p.A321 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112017003685T5 (en) 2016-07-22 2019-05-02 Denso Corporation Vehicle air conditioning unit

Similar Documents

Publication Publication Date Title
Money Are mushrooms medicinal?
CN102153668B (en) Anticancer Armillaria luteovirens polysaccharide and extraction process thereof
JP6209579B2 (en) Pharmaceutical composition that is regarded as a supplementary medicine
CN104225217B (en) A kind of Chinese medicine preparation for treating coronary heart disease and preparation method thereof
CN105747232A (en) Polysaccharide composition and application thereof
CN105504076B (en) A kind of radix tetrastigme root tuber polysaccharide acted on antipyretic and anti-inflammatory and application thereof
CN102551058A (en) Chinese medicinal health-care product with function of enhancing immunity
CN103830301A (en) Flos chrysanthemi with liver tonifying function and application thereof
CN103330211B (en) A kind of composition and method of making the same and application with immunoloregulation function
JP2017105743A (en) Prophylactic and therapeutic method of lifestyle disease, such as cancer using rehmannia glutinosa and polygonatum falcatum
CN103690574A (en) Poria-containing traditional Chinese medicine combination for enhancing immunity and preparation method of poria-containing traditional Chinese medicine combination
Liu et al. The Chinese medicine Kuan-Sin-Yin improves liver function in patients with chronic hepatitis C: A randomised and placebo-controlled trial
CN102319276A (en) Application of trapa acornis nakai shell extract to preparation of medicaments for protecting livers
CN106135878A (en) Jilin Radix Ginseng oligopeptide purposes in preparation improves the food with sexual function improving or health food
CN101669984A (en) Anti-fatigue immuno-regulation Chinese medicinal product
Koike et al. Efficacy of porcine placental extract on shoulder stiffness in climacteric women
CN103330721A (en) Holothurian flower extract for treatment of female POF and its preparation method
CN1296089C (en) Zedoary injection preparation and its preparing method
CN106309758A (en) Pharmaceutical composition with efficacy of resisting gastrointestinal cancer
CN102961443B (en) Rhizoma menispermi antineoplastic extract, Preparation method and use
CN101518645A (en) Application of marine collagen peptide in preparing drugs, health care food or food for protecting renal function and delaying the process of chronic renal failure
US9060989B2 (en) Method for treating or relieving inflammatory bowel disease
CN104825499A (en) Application of grifron maitake extraction in preparation of anti-depression drug
CN102232957B (en) Use of 3-acetoxyl-8, 24-lanostadiene-21-acid in preparing medicines for preventing or treating liver cancer or breast cancer
CN109568329A (en) The application of glycyrrhizic acid and its pharmaceutically acceptable salt in preparation antidepressant

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171121

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20180514

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20180531

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180626

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190108